Aadi Bioscience Raises $23M
socalTECH
MAY 8, 2017
Pacific Palisades-based Aadi Bioscience , a biopharmaceuticals firm focused on diseases related to mTOR activation, said it has raised $23M in a Series A funding round. The round was led by Hermed Capital and also included Celgene Corporation, Vivo Capital, Decheng Capital, the Helsinn Investment Fund and Star Summit Ventures.
Let's personalize your content